Glori Energy Inc. (GLRI)
Houston, TX, US
Glori Energy Inc. operates as an energy technology and oil production enterprise, supplying services to exploration and production firms across North America and Brazil. The company functions through two primary divisions: its Oil and Gas segment, which focuses on the development and output of crude oil and natural gas assets, and its AERO Services segment. The AERO Services division delivers biotechnological remedies for enhanced oil recovery (EOR). This EOR method involves a two-part approach: an initial analysis phase, where reservoir samples are scrutinized to assess the AERO system's suitability; followed by a field deployment phase, which entails installing mobile injection equipment on-site. Glori Energy Inc. was established in 2005 and has its headquarters in Houston, Texas.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | -50.00% | +0.00% | +0.00% | +0.00% | -50.00% | -99.26% | -99.96% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Shell Companies: +20.6%-50.0% Q4'16: -47.0% (vs Q4'15)
-
EPS growth Shell Companies: -12.3%+63.2% ★ Q4'16: +85.9% (vs Q4'15)
-
FCF margin FCF growth · Shell Companies: +8.7%-275.3% Q4'16: -143.5% (vs Q4'15)
-
EBIT margin Shell Companies: +0.0%-244.3% Q4'16: -315.1% (vs Q4'15)
-
ROIC Shell Companies: +0.0%-310.4% Q4'16: -331.5% (vs Q4'15)
-
Share dilution Shell Companies: -10.2%-2.1% ★ Q4'16: -2.3% (vs Q4'15)
-
Debt / EBITDA Net debt/EBITDA · Shell Companies: 0.00×-1.09× Q4'16: -0.96× (vs Q4'15)
Owner Earnings
Ownership Overview
Ownership breakdown not available.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-11-11 | Neuman Eric C | Director | — | D | Common Stock | 0 | 0.00 | — | 138,125 | — | ↗ |
| 2015-01-28 | KISHORE GANESH | Director | A-Award | A | Common Stock | 24,194 | 0.00 | — | 24,194 | — | ↗ |
| 2015-01-28 | CLARKE JOHN U | Director | A-Award | A | Common Stock | 24,194 | 0.00 | — | 25,918 | — | ↗ |
| 2014-04-14 | SCHULHOF MICHAEL | Director | — | I | Common Stock | 0 | 0.00 | — | 2,823,915 | — | ↗ |
| 2014-04-14 | Oxford Bioscience Partners V L.P. | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 4,196,221 | — | ↗ |
| 2014-04-14 | KISHORE GANESH | Director | — | I | Common Stock | 0 | 0.00 | — | 3,104,523 | — | ↗ |
| 2014-04-14 | HICKS THOMAS O | Director | — | I | Common Stock Warrants (right to buy) | 500,000 | 10.00 | 5.00M | 0 | — | ↗ |
| 2014-04-14 | CLARKE JOHN U | Director | — | D | Stock Options | 82,759 | 1.16 | 96.0K | 0 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Rajendra Kumar Pachauri | Founder | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GLRI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
